Monte Carlo calculation and experimental detemination of the relative dose rate distribution around the new I-125 brachytherapy source IsoSeed I25. S17plus. Results are reported in a form suitable for clinical use and compared to corresponding data for other commercially available I-125 sources of similar design.

Start-end : 2014

Financed by Eckert & Ziegler BEBIG (Berlin, Germany)

Results are published in peer reviewed literature. The interested reader can find the papers  following the link.